Semaglutide Peptide Calculator: What These Tools Are and Why They Don't Apply to Wegovy

Step 1, Understand what a peptide calculator is actually for

A peptide calculator takes three inputs: the mass of powder in a vial, the volume of bacteriostatic water added, and the target dose per injection. It then tells you how many units to draw in a syringe. That workflow exists because research-grade peptides are sold as lyophilised (freeze-dried) powder with no pre-set concentration. The person reconstituting the vial decides how much water to add, and the calculator works out the arithmetic from there.

This process has a legitimate place in clinical research settings. It has no place in the hands of someone self-administering at home, and it has no connection whatsoever to Wegovy as sold through a licensed UK pharmacy. If you've found yourself reading about semaglutide mixing calculators or bacteriostatic water ratios, the content you were reading was almost certainly about unlicensed research compounds, not the medicine a UK prescriber would assess you for.

The distinction matters enormously. A small arithmetic error in reconstitution can produce a concentration ten times too high or too low. Neither outcome is safe. Licensed pens eliminate that variable entirely.

Step 2, See how Wegovy's pre-filled pens make reconstitution irrelevant

Wegovy works through a once-weekly subcutaneous injection. Each pen contains a precisely manufactured semaglutide solution at a fixed concentration, filled and sealed under pharmaceutical-grade conditions by Novo Nordisk. You dial the pen to the right setting (or, in the case of the newer 7.2 mg single-dose pen approved by the MHRA in April 2026, there is no dial at all) and inject. The NHS medicines page for semaglutide covers how to use the pen correctly, including injection sites and storage.

The licensed titration path runs from 0.25 mg up through 0.5 mg, 1.0 mg, 1.7 mg and 2.4 mg, increasing roughly every four weeks under prescriber guidance. The 7.2 mg option follows the same graduated path, with 2.4 mg as the ceiling before moving up. None of those steps involve any measuring by the patient. The prescriber adjusts the dose; the pen delivers it. Tools like a semaglutide dilution calculator or a Wegovy dose calculator are simply not part of that process.

One practical check that takes under a minute: look at any semaglutide product being sold online and ask whether it requires you to add water before use. If it does, it is not a licensed Wegovy pen. Full stop.

Step 3, Recognise why unlicensed semaglutide peptides are a safety concern

The MHRA has been clear and consistent on this. In October 2023 it issued warnings about fake and unlicensed weight-loss injectables circulating online, and enforcement has intensified since: approximately 20 million doses of illegally traded weight-loss medicines with an estimated street value of around £45 million were seized in 2025 alone, including counterfeit tirzepatide pens from a site in Northampton. Unlicensed semaglutide peptide vials fall into the same risk category. You can report suspect sellers or products directly through the MHRA Yellow Card scheme.

The risks are not theoretical. Unverified powders may contain the wrong substance, the wrong concentration, or contaminants from non-sterile manufacturing. Reconstitution errors stack on top of that. And without a prescriber reviewing your health history, contraindications (a history of pancreatitis, certain thyroid conditions, current medicines that interact with semaglutide) go unchecked.

For context on what the legitimate supply chain looks like, the Wegovy overview on this site sets out the licensing history, what the clinical trials showed, and how access works in the UK. For people ready to explore whether Wegovy is appropriate for them through a regulated route, buying Wegovy online through a GPhC-registered pharmacy is the only legal path once a prescriber has assessed suitability.

Step 4, Understand what a legitimate assessment actually involves

To be prescribed Wegovy lawfully in the UK, you need a clinical assessment from a registered prescriber. The licensed eligibility criteria set by the MHRA cover adults with a BMI of 30 or above, or 27 and above where a weight-related health condition is present, but BMI alone does not determine suitability. A prescriber looks at your full medical history, current medications, and any contraindications before making a decision. That assessment protects you; it also means the prescription reflects your actual situation rather than a calculator's output.

NICE's appraisal of semaglutide for weight management, TA875, sets out the evidence base that underpins clinical decision-making on this medicine. Private routes like the one available through nume follow the same clinical standards: a GPhC-registered independent prescriber reviews every consultation personally, the same day. No algorithm makes the call.

If you came to this page genuinely curious about whether semaglutide could help with weight management, the semaglutide information page is a good next read. And if you'd like a prescriber to look at your specific circumstances, our team is available seven days a week.